TWD 75.9
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 126.79 Million TWD | -28.12% |
2022 | 176.4 Million TWD | 0.0% |
2021 | - TWD | 0.0% |
2020 | - TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 103.39 Million TWD | -18.46% |
2024 Q2 | 130.36 Million TWD | 26.09% |
2023 FY | 126.79 Million TWD | -28.12% |
2023 Q3 | 140.05 Million TWD | -7.25% |
2023 Q2 | 151 Million TWD | 12.71% |
2023 Q1 | 133.98 Million TWD | -24.05% |
2023 Q4 | 126.79 Million TWD | -9.46% |
2022 Q4 | 176.4 Million TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Allied Biotech Corporation | 601.47 Million TWD | 78.919% |
GeneFerm Biotechnology Co., Ltd. | 155.43 Million TWD | 18.423% |
Easywell Biomedicals, Inc. | 42.17 Million TWD | -200.678% |
TTY Biopharm Company Limited | 1.09 Billion TWD | 88.43% |
Synmosa Biopharma Corporation | 1.59 Billion TWD | 92.066% |
Orient EuroPharma Co., Ltd. | 1.09 Billion TWD | 88.429% |
Center Laboratories, Inc. | 269.22 Million TWD | 52.903% |
Tien Liang BioTech Co., Ltd. | 75.79 Million TWD | -67.29% |
Orient Pharma Co., Ltd. | 233.97 Million TWD | 45.806% |
InnoPharmax Inc. | 22.24 Million TWD | -470.062% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 138.8 Million TWD | 8.651% |
Excelsior Biopharma Inc. | 217.28 Million TWD | 41.643% |
DV Biomed Co., Ltd. | 96.51 Million TWD | -31.378% |
Handa Pharmaceuticals, Inc. | - TWD | -Infinity% |
UniPharma Co., Ltd. | 28.94 Million TWD | -338.084% |
Anxo Pharmaceutical Co., Ltd. | 283.86 Million TWD | 55.331% |
Alar Pharmaceuticals Inc. | - TWD | -Infinity% |
Winston Medical Supply Co., Ltd. | 115.73 Million TWD | -9.559% |
Mercury Biopharmaceutical Corporation | 10.07 Million TWD | -1158.676% |
Bioray Biotech Co., Ltd | 55.95 Million TWD | -126.629% |
TSH Biopharm Corporation Limited | 118.39 Million TWD | -7.098% |